Wealthspire Advisors (Maryland)’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-536
Closed -$39K 2202
2019
Q1
$39K Buy
536
+498
+1,311% +$35.4K ﹤0.01% 995
2018
Q4
$2K Sell
38
-13
-25% -$815 ﹤0.01% 2157
2018
Q3
$4K Sell
51
-32
-39% -$2.36K ﹤0.01% 1954
2018
Q2
$6K Buy
83
+10
+14% +$573 ﹤0.01% 1751
2018
Q1
$4K Buy
73
+9
+14% +$490 ﹤0.01% 1954
2017
Q4
$3K Buy
64
+16
+33% +$935 ﹤0.01% 2038
2017
Q3
$3K Buy
48
+24
+100% +$1.23K ﹤0.01% 1935
2017
Q2
$1K Buy
24
+3
+14% +$191 ﹤0.01% 2142
2017
Q1
$1K Buy
21
+18
+600% +$1.12K ﹤0.01% 1867
2016
Q4
$0 Hold
3
﹤0.01% 1865
2016
Q3
$0 Hold
3
﹤0.01% 1821
2016
Q2
$0 Hold
3
﹤0.01% 1831
2016
Q1
$0 Sell
3
-129
-98% -$4.33K ﹤0.01% 1871
2015
Q4
$6K Buy
+132
New +$5.49K ﹤0.01% 1324

Other funds holding SGEN

Wealthspire Advisors (Maryland)'s SGEN Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Seagen Inc. Common Stock (SGEN) in Q2 2019, closing a stake of 536 shares — an estimated $39K sold.

Wealthspire Advisors (Maryland) first reported a position in SGEN in Q4 2015 and held it in 14 quarters. The position peaked at $39K in Q1 2019. 324 funds tracked by Wall St. Rank hold SGEN as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Seagen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 536 Seagen Inc. Common Stock shares in Q2 2019, an estimated $39K.
  • Wealthspire Advisors (Maryland) first reported a position in Seagen Inc. Common Stock in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Seagen Inc. Common Stock position peaked at $39K in Q1 2019.
  • 324 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.